Accepted for Publication: April 27, 2021.
Published Online: July 6, 2021. doi:10.1001/jamainternmed.2021.2790
Corresponding Author: Kevin L. Schwartz, MD, Public Health Ontario, 480 University Ave, Ste 300, Toronto, ON M5G 1V2, Canada (kevin.schwartz@oahpp.ca).
Author Contributions: Mr Neish had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Schwartz, Ivers, Langford, Taljaard, Daneman, Alloo, Silverman, Grimshaw, Wu, Garber.
Acquisition, analysis, or interpretation of data: Schwartz, Ivers, Langford, Taljaard, Neish, Brown, Leung, Daneman, Alloo, Shing, Grimshaw, Leis.
Drafting of the manuscript: Schwartz, Neish, Silverman.
Critical revision of the manuscript for important intellectual content: Ivers, Langford, Taljaard, Brown, Leung, Daneman, Alloo, Silverman, Shing, Grimshaw, Leis, Wu, Garber.
Statistical analysis: Taljaard, Neish, Brown, Shing.
Obtained funding: Schwartz.
Administrative, technical, or material support: Schwartz, Langford, Leung, Leis, Wu, Garber.
Supervision: Taljaard, Silverman, Garber.
Other—partnership development and implementation support: Alloo.
Conflict of Interest Disclosures: Dr Ivers reported support from a Canada Research Chair (Tier 2) in Implementation of Evidence-Based Practice and a Clinician Scholar award from the Department of Family and Community Medicine at the University of Toronto, as well as grants from the Canadian Institutes of Health Research and the Joint Programming Initiative on Antimicrobial Resistance outside the submitted work. Dr Alloo reported grants from the University of Toronto and personal fees from Novo Nordisk, Roche, Eli Lilly, AstraZeneca, Memotext, the Centre for Addiction and Mental Health, Trillium Health Partners, Ontario College of Family Physicians, and the Section on General and Family Practice at Ontario Medical Association outside the submitted work. Dr Leis reported personal fees from Choosing Wisely Canada during the conduct of the study. No other disclosures were reported.
Funding/Support: This study was funded by Public Health Ontario and a Canadian Institutes of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials grant (application No. 398514).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The lead author, Dr Schwartz, affirms that this article is an honest, accurate, and transparent account of the study being reported. No important aspects have been omitted, and any discrepancies from the original protocol have been explained.
Data Sharing Statement: See Supplement 3.
Additional Contributions: We thank our lived-experience patient partners Emily Angl, BMSc, and Barbara Sklar, RN, BAEd/ADED, for their contributions to this study. Ms Angl received compensation through the study funding for her time consulting on this article.
2.Low
M , Neuberger
A , Hooton
TM ,
et al. Association between urinary community-acquired fluoroquinolone-resistant
Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study.
Lancet Infect Dis. 2019;19(4):419-428. doi:
10.1016/S1473-3099(18)30676-5
PubMedGoogle ScholarCrossref 3.Bell
BG , Schellevis
F , Stobberingh
E , Goossens
H , Pringle
M . A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance.
BMC Infect Dis. 2014;14(1):13. doi:
10.1186/1471-2334-14-13
PubMedGoogle ScholarCrossref 4.Costelloe
C , Metcalfe
C , Lovering
A , Mant
D , Hay
AD . Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.
BMJ. 2010;340:c2096. doi:
10.1136/bmj.c2096
PubMedGoogle ScholarCrossref 5.Nelson
RE , Hatfield
KM , Wolford
H ,
et al. National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States.
Clin Infect Dis. 2021;72(suppl 1):S17-S26. doi:
10.1093/cid/ciaa1581PubMedGoogle ScholarCrossref 8.Schwartz
KL , Langford
BJ , Daneman
N ,
et al. Unnecessary antibiotic prescribing in a Canadian primary care setting: a descriptive analysis using routinely collected electronic medical record data.
CMAJ Open. 2020;8(2):E360-E369. doi:
10.9778/cmajo.20190175
PubMedGoogle ScholarCrossref 10.Chua
KP , Fischer
MA , Linder
JA . Appropriateness of outpatient antibiotic prescribing among privately insured US patients: ICD-10-CM based cross sectional study.
BMJ. 2019;364:k5092. doi:
10.1136/bmj.k5092
PubMedGoogle Scholar 13.Fernandez-Lazaro
CI , Brown
KA , Langford
BJ , Daneman
N , Garber
G , Schwartz
KL . Late-career physicians prescribe longer courses of antibiotics.
Clin Infect Dis. 2019;69(9):1467-1475. doi:
10.1093/cid/ciy1130
PubMedGoogle ScholarCrossref 14.King
LM , Hersh
AL , Hicks
LA , Fleming-Dutra
KE . Duration of outpatient antibiotic therapy for common outpatient infections, 2017.
Clin Infect Dis. 2020;ciaa1404.
PubMedGoogle Scholar 18.McCullough
AR , Rathbone
J , Parekh
S , Hoffmann
TC , Del Mar
CB . Not in my backyard: a systematic review of clinicians’ knowledge and beliefs about antibiotic resistance.
J Antimicrob Chemother. 2015;70(9):2465-2473. doi:
10.1093/jac/dkv164
PubMedGoogle ScholarCrossref 19.Altamimi
S , Khalil
A , Khalaiwi
KA , Milner
RA , Pusic
MV , Al Othman
MA . Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children.
Cochrane Database Syst Rev. 2012;(8):CD004872. doi:
10.1002/14651858.CD004872.pub3
PubMedGoogle Scholar 21.Moran
GJ , Fang
E , Corey
GR , Das
AF , De Anda
C , Prokocimer
P . Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
Lancet Infect Dis. 2014;14(8):696-705. doi:
10.1016/S1473-3099(14)70737-6
PubMedGoogle ScholarCrossref 22.Kim
DK , Kim
JH , Lee
JY ,
et al. Reappraisal of the treatment duration of antibiotic regimens for acute uncomplicated cystitis in adult women: a systematic review and network meta-analysis of 61 randomised clinical trials.
Lancet Infect Dis. 2020;20(9):1080-1088. doi:
10.1016/S1473-3099(20)30121-3
PubMedGoogle ScholarCrossref 25.Kiefe
CI , Allison
JJ , Williams
OD , Person
SD , Weaver
MT , Weissman
NW . Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial.
JAMA. 2001;285(22):2871-2879. doi:
10.1001/jama.285.22.2871
PubMedGoogle ScholarCrossref 28.Gulliford
MC , Prevost
AT , Charlton
J ,
et al. Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial.
BMJ. 2019;364:l236. doi:
10.1136/bmj.l236
PubMedGoogle Scholar 29.Hicks
LA , Bartoces
MG , Roberts
RM ,
et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011.
Clin Infect Dis. 2015;60(9):1308-1316. doi:
10.1093/cid/civ076
PubMedGoogle Scholar 30.Schwartz
KL , Chen
C , Langford
BJ ,
et al. Validating a popular outpatient antibiotic database to reliably identify high prescribing physicians for patients 65 years of age and older.
PLoS One. 2019;14(9):e0223097. doi:
10.1371/journal.pone.0223097
PubMedGoogle Scholar 34.Hooper
R , Forbes
A , Hemming
K , Takeda
A , Beresford
L . Analysis of cluster randomised trials with an assessment of outcome at baseline.
BMJ. 2018;360:k1121. doi:
10.1136/bmj.k1121
PubMedGoogle Scholar 37.Hemkens
LG , Saccilotto
R , Reyes
SL ,
et al. Personalized prescription feedback to reduce antibiotic overuse in primary care: rationale and design of a nationwide pragmatic randomized trial.
BMC Infect Dis. 2016;16(1):421. doi:
10.1186/s12879-016-1739-0
PubMedGoogle ScholarCrossref 38.Fox
CR , Doctor
JN , Goldstein
NJ , Meeker
D , Persell
SD , Linder
JA . Details matter: predicting when nudging clinicians will succeed or fail.
BMJ. 2020;370:m3256. doi:
10.1136/bmj.m3256
PubMedGoogle Scholar 40.Hrisos
S , Eccles
M , Johnston
M ,
et al. Developing the content of two behavioural interventions: using theory-based interventions to promote GP management of upper respiratory tract infection without prescribing antibiotics #1.
BMC Health Serv Res. 2008;8:11. doi:
10.1186/1472-6963-8-11
PubMedGoogle ScholarCrossref 42.Ivers
N , Barnsley
J , Upshur
R ,
et al. “My approach to this job is...one person at a time”: perceived discordance between population-level quality targets and patient-centred care.
Can Fam Physician. 2014;60(3):258-266.
PubMedGoogle Scholar 43.Kitano
T , Langford
BJ , Brown
KA ,
et al. The association between high and unnecessary antibiotic prescribing: a cohort study using family physician electronic medical records.
Clin Infect Dis. 2021;72(9):e345-e351. doi:
10.1093/cid/ciaa1139
PubMedGoogle ScholarCrossref